Amgen Inc. (AMGN) Q2 2011 Earnings Results

Amgen Beats on EPS, Stock Up 2.38%

Amgen's earnings report shows a positive surprise in EPS, which likely contributed to the 2.38% increase in stock price. Investors may view the EPS beat as a sign of strong underlying performance, even though revenue figures were not disclosed. The lack of guidance could lead to uncertainty, but management's optimistic tone may reassure some investors.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.37	N/A	+5.55%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's financial health. They emphasized their focus on improving operational metrics.

Management expressed satisfaction with the EPS performance despite the lack of revenue guidance.

They highlighted ongoing efforts to enhance operational efficiency.

Amgen Beats on EPS, Stock Up 2.38%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Beats on EPS, Stock Up 2.38%

Key numbers

Management commentary